|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.50 EUR | -1.29% |
|
-0.11% | +41.62% |
| 12-10 | MedTech Stocks Diverge Following Exane Report: 'A Split 2026' | DP |
| 12-04 | Britain's Frasers backs Hugo Boss' strategy and executive team | RE |
| Capitalization | 26.79B 31.44B 25.02B 23.54B 43.34B 2,848B 47.35B 292B 113B 1,343B 118B 115B 4,898B | P/E ratio 2025 * |
17.7x | P/E ratio 2026 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise value | 38.11B 44.74B 35.6B 33.5B 61.67B 4,052B 67.37B 416B 161B 1,910B 168B 164B 6,969B | EV / Sales 2025 * |
1.69x | EV / Sales 2026 * | 1.57x |
| Free-Float |
73.04% | Yield 2025 * |
2.3% | Yield 2026 * | 2.47% |
Last Transcript: Fresenius SE & Co. KGaA
| 1 day | -1.29% | ||
| 1 week | -0.11% | ||
| Current month | +0.36% | ||
| 1 month | -4.56% | ||
| 3 months | +2.06% | ||
| 6 months | +7.37% | ||
| Current year | +41.62% |
| 1 week | 46.79 |  | 48.48 |
| 1 month | 46.06 | | 49.21 |
| Current year | 31.6 | | 50.74 |
| 1 year | 31.6 | | 50.74 |
| 3 years | 23.29 | | 50.74 |
| 5 years | 19.69 | | 50.74 |
| 10 years | 19.69 | | 80.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 57 | 2022-09-30 |
Sara Hennicken
DFI | Director of Finance/CFO | 45 | 2022-08-31 |
Michael Moser
CMP | Compliance Officer | 49 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 71 | 2015-05-19 |
| Director/Board Member | 65 | 2016-05-12 | |
| Director/Board Member | 51 | 2007-12-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.05% | 962 M€ | -.--% | - |
| 1.01% | 0 M€ | -.--% | - |
| 0.92% | 1 M€ | +54.47% | - |
| 0.92% | 1 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.29% | -0.11% | +36.53% | +82.55% | 31.44B | |
| +0.50% | -0.40% | +55.38% | +99.72% | 111B | |
| -1.74% | +5.01% | +60.19% | -23.48% | 101B | |
| -0.23% | +2.79% | -14.28% | +17.68% | 24.08B | |
| -0.21% | +2.24% | +13.95% | +16.10% | 21.9B | |
| +0.55% | +0.03% | +16.97% | +22.52% | 20.31B | |
| +1.65% | +2.04% | +63.58% | +77.87% | 18.33B | |
| +0.85% | -5.05% | +47.31% | +350.93% | 17.52B | |
| -0.88% | -3.67% | +19.39% | +73.36% | 13.91B | |
| +0.38% | +0.07% | -11.60% | +34.92% | 13.43B | |
| Average | -0.04% | +0.21% | +28.74% | +75.22% | 37.24B | |
| Weighted average by Cap. | -0.33% | +1.21% | +42.32% | +57.90% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 22.55B 26.47B 21.06B 19.82B 36.49B 2,397B 39.86B 246B 95.37B 1,130B 99.32B 97.23B 4,123B | 23.74B 27.86B 22.17B 20.86B 38.41B 2,524B 41.96B 259B 100B 1,190B 105B 102B 4,340B |
| Net income | 1.53B 1.8B 1.43B 1.35B 2.48B 163B 2.71B 16.7B 6.48B 76.76B 6.75B 6.6B 280B | 1.92B 2.25B 1.79B 1.69B 3.1B 204B 3.39B 20.92B 8.11B 96.14B 8.45B 8.27B 351B |
| Net Debt | 11.32B 13.29B 10.58B 9.95B 18.32B 1,204B 20.02B 123B 47.89B 568B 49.88B 48.83B 2,071B | 10.54B 12.38B 9.85B 9.27B 17.06B 1,121B 18.64B 115B 44.6B 528B 46.44B 45.46B 1,928B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 47.56 € | -0.73% | 584,654 |
| 25-12-11 | 47.91 € | -0.27% | 693,886 |
| 25-12-10 | 48.04 € | +2.30% | 786,413 |
| 25-12-09 | 46.96 € | -1.45% | 424,309 |
| 25-12-08 | 47.65 € | +0.21% | 507,785 |
Delayed Quote Xetra, December 12, 2025 at 12:58 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FRE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition